CDI

439.8

-0.72%↓

KESKOB.FI

19.2

-0.16%↓

SZU

10

+0.1%↑

AGRB

11.2

0%↓

KOF

31.75

+1.28%↑

CDI

439.8

-0.72%↓

KESKOB.FI

19.2

-0.16%↓

SZU

10

+0.1%↑

AGRB

11.2

0%↓

KOF

31.75

+1.28%↑

CDI

439.8

-0.72%↓

KESKOB.FI

19.2

-0.16%↓

SZU

10

+0.1%↑

AGRB

11.2

0%↓

KOF

31.75

+1.28%↑

CDI

439.8

-0.72%↓

KESKOB.FI

19.2

-0.16%↓

SZU

10

+0.1%↑

AGRB

11.2

0%↓

KOF

31.75

+1.28%↑

CDI

439.8

-0.72%↓

KESKOB.FI

19.2

-0.16%↓

SZU

10

+0.1%↑

AGRB

11.2

0%↓

KOF

31.75

+1.28%↑

Search

Colruyt SA

Cerrado

SectorConsumo defensivo

37.66 0.32

Resumen

Variación precio

24h

Actual

Mínimo

37.08

Máximo

37.68

Métricas clave

By Trading Economics

Ingresos

-48M

143M

Ventas

109M

5.5B

P/B

Media del Sector

13.934

27.757

BPA

1.17

Rentabilidad por dividendo

3.64

Margen de beneficio

2.59

Empleados

33,000

EBITDA

-11M

434M

Recomendaciones

By TipRanks

Recomendaciones

Vender

Estimación a 12 meses

-20.42% downside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

3.64%

3.32%

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

72M

4.6B

Apertura anterior

37.34

Cierre anterior

37.66

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

70 / 150 Clasificación en Consumer defensive

Colruyt SA Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

4 ago 2025, 21:42 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4 ago 2025, 21:21 UTC

Ganancias
Principales Movimientos del Mercado

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4 ago 2025, 20:45 UTC

Ganancias

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4 ago 2025, 19:15 UTC

Principales Movimientos del Mercado

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4 ago 2025, 23:41 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

4 ago 2025, 23:41 UTC

Charlas de Mercado

Nikkei May Rise on Fed Stimulus Hopes

4 ago 2025, 23:28 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

4 ago 2025, 23:28 UTC

Charlas de Mercado

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4 ago 2025, 21:30 UTC

Ganancias

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 ago 2025, 21:21 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4 ago 2025, 21:18 UTC

Ganancias

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 ago 2025, 20:25 UTC

Charlas de Mercado

India Hits Back Over Russian Oil Purchases -- Market Talk

4 ago 2025, 20:25 UTC

Ganancias

Transocean 2Q Loss $938M >RIG

4 ago 2025, 20:25 UTC

Ganancias

Transocean 2Q Loss/Shr $1.06 >RIG

4 ago 2025, 20:18 UTC

Ganancias

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4 ago 2025, 20:15 UTC

Ganancias

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4 ago 2025, 20:14 UTC

Ganancias

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4 ago 2025, 20:14 UTC

Ganancias

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4 ago 2025, 20:14 UTC

Ganancias

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4 ago 2025, 20:13 UTC

Ganancias

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4 ago 2025, 20:09 UTC

Ganancias

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4 ago 2025, 20:06 UTC

Ganancias

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4 ago 2025, 20:01 UTC

Ganancias

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4 ago 2025, 20:01 UTC

Ganancias

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4 ago 2025, 20:01 UTC

Ganancias

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4 ago 2025, 20:01 UTC

Ganancias

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4 ago 2025, 19:41 UTC

Charlas de Mercado

U.S. Natural Gas Futures Settle Lower -- Market Talk

4 ago 2025, 19:28 UTC

Charlas de Mercado

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4 ago 2025, 19:07 UTC

Charlas de Mercado

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4 ago 2025, 18:27 UTC

Charlas de Mercado

Gold Climbs on Rate Cut Speculation -- Market Talk

Comparación entre iguales

Cambio de precio

Colruyt SA Esperado

Precio Objetivo

By TipRanks

-20.42% caída

Estimación a 12 meses

Media 27.28 EUR  -20.42%

Máximo 37 EUR

Mínimo 21 EUR

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Colruyt SA Dist en los últimos 3 meses.

Consenso

By TipRanks

Vender

4 ratings

0

Comprar

2

Mantener

2

Vender

Sentimiento

By Acuity

70 / 150 Clasificación en Consumo defensivo

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Colruyt SA

Colruyt Group N.V., together with its subsidiaries, engages in the retail, wholesale, food service, and other activities in Belgium, France, and internationally. It operates through three segments: Retail, Wholesale and Foodservice, and Other Activities. The company offers food, health and well-being products, and non-food products. It provides printing and document management solutions. The company offers its products and services under the Bike Republic, Bio-Planet, Boni Selection, Collect&Go, Colruyt Group Academy, Colruyt Lowest Prices, Colruyt Prix Qualité, Comarkt, Cru, Everyday, The Fashion Society, Graindor, Jims, Newpharma, Okay, Spar Colruyt Group, Xtra, Codifrance, Colex, DATS 24, Degrenne Distribution, Retail Partners Colruyt Group, Solucious, Symeta Hybrid, Dreamland, Foodbag, MyComfort24, and Yoboo brands. It serves its products to wholesalers, commercial, and affiliated independent merchants, as well as hospitals, SMEs, and hospitality industries. The company was formerly known as Etn. Fr. Colruyt NV and changed its name to Colruyt Group N.V. in October 2023. The company was founded in 1928 and is headquartered in Halle, Belgium.